环状 RGD 非肽多聚体中酪氨酸的重要性:走向 αvβ6 整合素靶向放射治疗药物

IF 3.597 Q2 Pharmacology, Toxicology and Pharmaceutics
MedChemComm Pub Date : 2024-04-19 DOI:10.1039/D4MD00073K
Neil Gerard Quigley, Maximilian Alexander Zierke, Beatrice Stefanie Ludwig, Frauke Richter, Nghia Trong Nguyen, Falco Reissig, Jakub Šimeček, Susanne Kossatz and Johannes Notni
{"title":"环状 RGD 非肽多聚体中酪氨酸的重要性:走向 αvβ6 整合素靶向放射治疗药物","authors":"Neil Gerard Quigley, Maximilian Alexander Zierke, Beatrice Stefanie Ludwig, Frauke Richter, Nghia Trong Nguyen, Falco Reissig, Jakub Šimeček, Susanne Kossatz and Johannes Notni","doi":"10.1039/D4MD00073K","DOIUrl":null,"url":null,"abstract":"<p >In a recent paper in this journal (<em>RSC Med. Chem.</em>, 2023, <strong>14</strong>, 2429), we described an unusually strong impact of regiospecific exchange of phenylalanines by tyrosines in 10 gallium-68-labeled trimers of certain cyclic RGD peptides, c[XRGDLAXp(<em>N</em>Me)K] (X = F or Y), on non-specific organ uptakes. We found that there was, in part, no correlation of liver uptake with established polarity proxies, such as the octanol–water distribution coefficient (log <em>D</em>). Since this observation could not be explained straightforwardly, we suggested that the symmetry of the compounds had resulted in a synergistic interaction of certain components of the macromolecules. In the present work, we investigated whether a comparable effect also occurred for a series of 5 tetramers labeled with lutetium-177. We found that in contrast to the trimers, liver uptake of the tetramers was well correlated to their polarity, indicating that the unusual observations along the trimer series indeed was a unique feature, probably related to their particular symmetry. Since the Lu-177 labeled tetramers are also potential agents for treatment of a variety of αvβ6-integrin expressing cancers, these were evaluated in mice bearing human lung adenocarcinoma xenografts. Due to their tumor-specific uptake and retention in biodistribution and SPECT imaging experiments, these compounds are considered a step forward on the way to αvβ6-integrin-targeted anticancer agents. Furthermore, we noticed that the presence of tyrosines in general had a positive impact on the <em>in vivo</em> performance of our peptide multimers. In view of the fact that a corresponding rule was already proposed in the context of protein engineering, we argue in favor of considering peptide multimers as a special class of small or medium-sized proteins. In summary, we contend that the performance of peptide multimers is less determined by the <em>in vitro</em> characteristics (particularly, affinity and selectivity) of monomers, but rather by the peptides' suitability for the overall macromolecular design concept, and peptides containing tyrosines are preferred.</p>","PeriodicalId":88,"journal":{"name":"MedChemComm","volume":" 6","pages":" 2018-2029"},"PeriodicalIF":3.5970,"publicationDate":"2024-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The importance of tyrosines in multimers of cyclic RGD nonapeptides: towards αvβ6-integrin targeted radiotherapeutics†\",\"authors\":\"Neil Gerard Quigley, Maximilian Alexander Zierke, Beatrice Stefanie Ludwig, Frauke Richter, Nghia Trong Nguyen, Falco Reissig, Jakub Šimeček, Susanne Kossatz and Johannes Notni\",\"doi\":\"10.1039/D4MD00073K\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >In a recent paper in this journal (<em>RSC Med. Chem.</em>, 2023, <strong>14</strong>, 2429), we described an unusually strong impact of regiospecific exchange of phenylalanines by tyrosines in 10 gallium-68-labeled trimers of certain cyclic RGD peptides, c[XRGDLAXp(<em>N</em>Me)K] (X = F or Y), on non-specific organ uptakes. We found that there was, in part, no correlation of liver uptake with established polarity proxies, such as the octanol–water distribution coefficient (log <em>D</em>). Since this observation could not be explained straightforwardly, we suggested that the symmetry of the compounds had resulted in a synergistic interaction of certain components of the macromolecules. In the present work, we investigated whether a comparable effect also occurred for a series of 5 tetramers labeled with lutetium-177. We found that in contrast to the trimers, liver uptake of the tetramers was well correlated to their polarity, indicating that the unusual observations along the trimer series indeed was a unique feature, probably related to their particular symmetry. Since the Lu-177 labeled tetramers are also potential agents for treatment of a variety of αvβ6-integrin expressing cancers, these were evaluated in mice bearing human lung adenocarcinoma xenografts. Due to their tumor-specific uptake and retention in biodistribution and SPECT imaging experiments, these compounds are considered a step forward on the way to αvβ6-integrin-targeted anticancer agents. Furthermore, we noticed that the presence of tyrosines in general had a positive impact on the <em>in vivo</em> performance of our peptide multimers. In view of the fact that a corresponding rule was already proposed in the context of protein engineering, we argue in favor of considering peptide multimers as a special class of small or medium-sized proteins. In summary, we contend that the performance of peptide multimers is less determined by the <em>in vitro</em> characteristics (particularly, affinity and selectivity) of monomers, but rather by the peptides' suitability for the overall macromolecular design concept, and peptides containing tyrosines are preferred.</p>\",\"PeriodicalId\":88,\"journal\":{\"name\":\"MedChemComm\",\"volume\":\" 6\",\"pages\":\" 2018-2029\"},\"PeriodicalIF\":3.5970,\"publicationDate\":\"2024-04-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"MedChemComm\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://pubs.rsc.org/en/content/articlelanding/2024/md/d4md00073k\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"MedChemComm","FirstCategoryId":"1085","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2024/md/d4md00073k","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

摘要

在本刊最近的一篇论文(RSC Med. Chem., 2023, 14, 2429)中,我们描述了在 10 个镓-68 标记的某些环状 RGD 肽三聚体 c[XRGDLAXp(NMe)K] (X = F 或 Y)中,苯丙氨酸与酪氨酸的区域特异性交换对非特异性器官摄取的异常强烈的影响。我们发现,肝脏摄取量与辛醇-水分配系数(log D)等已确定的极性代用指标没有部分相关性。由于无法直接解释这一现象,我们认为化合物的对称性导致了大分子中某些成分的协同作用。在本研究中,我们研究了用镥-177 标记的一系列 5 四聚体是否也会产生类似的效果。我们发现,与三聚体不同,肝脏对四聚体的吸收与它们的极性有很好的相关性,这表明沿着三聚体系列的不寻常观察确实是一个独特的特征,可能与它们的特殊对称性有关。由于 Lu-177 标记的四聚体也是治疗多种表达 αvβ6 整合素的癌症的潜在药物,因此我们对这些四聚体进行了小鼠肺腺癌异种移植评估。由于这些化合物在生物分布和 SPECT 成像实验中具有肿瘤特异性摄取和保留,因此被认为是在αvβ6 整合素靶向抗癌剂的道路上迈出的一步。此外,我们还注意到,酪氨酸的存在一般会对多肽多聚物的体内性能产生积极影响。鉴于蛋白质工程中已经提出了相应的规则,我们主张将多肽多聚物视为一类特殊的中小型蛋白质。总之,我们认为多肽多聚物的性能不太取决于单体的体外特性(特别是亲和性和选择性),而是取决于多肽是否适合整个大分子设计概念,而含有酪氨酸的多肽是首选。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

The importance of tyrosines in multimers of cyclic RGD nonapeptides: towards αvβ6-integrin targeted radiotherapeutics†

The importance of tyrosines in multimers of cyclic RGD nonapeptides: towards αvβ6-integrin targeted radiotherapeutics†

The importance of tyrosines in multimers of cyclic RGD nonapeptides: towards αvβ6-integrin targeted radiotherapeutics†

In a recent paper in this journal (RSC Med. Chem., 2023, 14, 2429), we described an unusually strong impact of regiospecific exchange of phenylalanines by tyrosines in 10 gallium-68-labeled trimers of certain cyclic RGD peptides, c[XRGDLAXp(NMe)K] (X = F or Y), on non-specific organ uptakes. We found that there was, in part, no correlation of liver uptake with established polarity proxies, such as the octanol–water distribution coefficient (log D). Since this observation could not be explained straightforwardly, we suggested that the symmetry of the compounds had resulted in a synergistic interaction of certain components of the macromolecules. In the present work, we investigated whether a comparable effect also occurred for a series of 5 tetramers labeled with lutetium-177. We found that in contrast to the trimers, liver uptake of the tetramers was well correlated to their polarity, indicating that the unusual observations along the trimer series indeed was a unique feature, probably related to their particular symmetry. Since the Lu-177 labeled tetramers are also potential agents for treatment of a variety of αvβ6-integrin expressing cancers, these were evaluated in mice bearing human lung adenocarcinoma xenografts. Due to their tumor-specific uptake and retention in biodistribution and SPECT imaging experiments, these compounds are considered a step forward on the way to αvβ6-integrin-targeted anticancer agents. Furthermore, we noticed that the presence of tyrosines in general had a positive impact on the in vivo performance of our peptide multimers. In view of the fact that a corresponding rule was already proposed in the context of protein engineering, we argue in favor of considering peptide multimers as a special class of small or medium-sized proteins. In summary, we contend that the performance of peptide multimers is less determined by the in vitro characteristics (particularly, affinity and selectivity) of monomers, but rather by the peptides' suitability for the overall macromolecular design concept, and peptides containing tyrosines are preferred.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
MedChemComm
MedChemComm BIOCHEMISTRY & MOLECULAR BIOLOGY-CHEMISTRY, MEDICINAL
CiteScore
4.70
自引率
0.00%
发文量
0
审稿时长
2.2 months
期刊介绍: Research and review articles in medicinal chemistry and related drug discovery science; the official journal of the European Federation for Medicinal Chemistry. In 2020, MedChemComm will change its name to RSC Medicinal Chemistry. Issue 12, 2019 will be the last issue as MedChemComm.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信